Newsroom

SEOUL, South Korea--(BUSINESS WIRE)--Magnachip Semiconductor Corporation (NYSE: MX, “Magnachip”), a designer and manufacturer of power semiconductor solutions, today announced that it will showcase its Medium-Voltage (MV) MOSFET portfolio for AI server and data center power systems at PCIM Europe 2026, which will be held from June 9 to 11, 2026, in Nuremberg, Germany. At Hall 6, Booth 337, Magnachip will exhibit its MV MOSFET solutions for server and data center power supply units (PSUs), high-...

DALLAS--(BUSINESS WIRE)--Jacobs' joint venture has been appointed as engineering services partner for Greater Western Water’s Infrastructure Planning and Delivery Program....

NEW YORK--(BUSINESS WIRE)--Ares Capital Corporation (“Ares Capital”) (NASDAQ: ARCC) and Ares Strategic Income Fund (“ASIF”) announced today renewals, commitment increases and enhanced terms for each of their respective bank-led Revolving Credit Facilities. Ares Capital increased the commitment on its existing credit facility by approximately $170 million to approximately $5.5 billion, decreased the funded borrowing costs by 0.10% per annum to reflect the elimination of the SOFR credit spread ad...

SCHLIEREN (ZURICH), Switzerland--(BUSINESS WIRE)--LimmaTech Biologics AG, a Swiss clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced entry into a definitive agreement to be acquired by Lilly. LimmaTech is developing vaccines against bacterial pathogens for which rising antimicrobial resistance is steadily closing therapeutic options, including Staphylococcus aureus, Neisseria gonorrhoeae, and Chlamydia trachomatis. The company's p...

TROY, Mich.--(BUSINESS WIRE)--Champion Homes, Inc. (NYSE: SKY) (“Champion Homes” or the “Company”) today announced financial results for its fourth quarter and full year ended March 28, 2026 (“fiscal 2026”). Fourth Quarter and Full Year Fiscal 2026 Highlights (compared to Fourth Quarter and Full Year Fiscal 2025, respectively, unless otherwise noted) 4QF26 net sales increased 4.6% to $621.3 million and FY26 net sales increased 7.3% to $2.7 billion 4QF26 net income decreased 18.4% to $29.7 milli...

TROY, Mich.--(BUSINESS WIRE)--Champion Homes, Inc. (NYSE: SKY) (“Champion” or “the Company”) today announced that it has entered into a definitive agreement to acquire the assets of Homes Direct representing 11 retail locations across key Western U. S. markets, including Arizona, California, Colorado, New Mexico and Oregon. These locations represent the majority of Homes Direct’s operating footprint and align closely with Champion’s manufacturing and distribution presence in the region. Homes D...

LONDON--(BUSINESS WIRE)--IHS Holding Limited (NYSE: IHS) (“IHS Towers”) group, one of the largest independent owners, operators, and developers of shared communications infrastructure in the world by tower count, has today published its 2025 Sustainability Report. The report covers sustainability activities from January 1, 2025 to December 31, 2025 and demonstrates IHS Towers’ continued commitment to its stakeholders, including, but not limited to, its employees, customers, suppliers, local com...

ボストン--(BUSINESS WIRE)--（ビジネスワイヤ） -- Kaname Capitalは本日、株式会社カワチ薬品（東証：2664）に関する100ページの投資家向けホワイト・ペーパーを公開しました。そして、河内伸二氏の解任、社外取締役・渡辺林治氏の解任を含むKaname Capitalの株主提案に賛同することを株主に要請しました。更に、取締役会に対して、現在の所有構造の見直しを含む、株主のための価値創出に向けたあらゆる道筋を検討する「独立した戦略検討委員会」の設置を求めました。 創業者の遺産、そしてその行方 河内良三郎氏と妻・河内タカ氏は、1960年に栃木県の一軒の薬局からスタートし、国内初のメガドラッグストア業態を開発することで、戦後日本において最も重要な小売企業の一つを築き上げました。良三郎氏は1960年代後半に米国視察でそのコンセプトを持ち帰り、30年以上にわたって日本でも通用することを証明しました。1990年代には、カワチ薬品はドラッグストア業界のモデルとなり、コスモス薬品やドラッグストア・ゲンキーの創業者は、カワチ薬品を手本にしたことを公言しています。2000年...

BOSTON--(BUSINESS WIRE)--Kaname Capital today released a 102-page investor white paper on Cawachi Limited (TSE: 2664) and called on shareholders to vote FOR its proposals at the 59th Annual General Meeting on June 11, 2026 — including the removal of President Kawachi Shinji and Outside Director Watanabe Rinji as Directors. Kaname Capital further called on the resulting Board of Directors to establish an Independent Strategic Review Committee to evaluate all paths to value creation, including th...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Jefferies Global Healthcare Conference on June 3, 2026 and will participate in a fireside chat at 12:45pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will b...